Orlistat and Zepbound are two U.S. Food and Drug Administration (FDA)-approved weight loss medications that work in different ...

GLP-1 receptor agonist weight loss drugs suppress appetite for food but may also reduce mood and desire for sex in some ...

Two drugs now generate almost two-thirds of the pharmaceutical giant's revenue.

Eli Lilly’s next-generation, investigational weight-loss drug is just a few clicks away from being delivered to your door.

A study published in JAMA Ophthalmology has identified a potential link between popular weight-loss medications and severe, ...

Despite the end of federal shortages of popular GLP-1 weight-loss medications, the market for compounded alternatives remains ...

In contrast, one research trial using GLP-1 drugs on obese research subjects did not show a benefit from GLP-1 in the ...

The FDA let one 79-year-old take an experimental obesity drug. That sure sounds like the president, but let’s examine the evidence.

It isn't approved by the FDA, but we found an experimental weight-loss drug called retatrutide for sale at a local convenience store.

Glucagon-like peptide-1 receptor agonist (GLP-1) drugs, such as semaglutide, have become well known for their ability to aid ...

"This application was not for the President," White House spokesman Kush Desai wrote on X about viral rumors regarding Trump's alleged use of retatrutide ...

The percentage of American adults who are currently taking a GLP-1 drug for weight loss is 11%, according to a new survey ...